Images

Filter by

Figure 2 Smoothed Probability Density Function for Values of Left Ventricular Ejection Fraction by Decade in Participants Free of Heart Failure Juxtaposed with Participants with Heart Failure
Figure 2: Smoothed Probability Density Function for Values of Left Ventricular Ejection Fraction by Decade in Participants Free of Heart Failure Juxtaposed with Participants with Heart Failure
Figure 1 Prevalence of Heart Failure with Preserved Ejection Fraction Expressed as Percentage of All Heart Failure Cases in Selected Epidemiological Studies across Different Countries
Figure 1: Prevalence of Heart Failure with Preserved Ejection Fraction Expressed as Percentage of All Heart Failure Cases in Selected Epidemiological Studies across Different Countries
Figure 4 Monitoring Screens Before and After Inhaled Nitric Oxide Introduction Patient 1
Figure 4: Monitoring Screens Before and After Inhaled Nitric Oxide Introduction (Patient 1)
Figure 3 Changes in Mechanical Circulatory Support Auxiliary Flow Rate
Figure 3: Changes in Mechanical Circulatory Support Auxiliary Flow Rate
Figure 2 Summary of Haemodynamic Responses After iNO Introduction
Figure 2: Summary of Haemodynamic Responses After iNO Introduction
Figure 1 Changes in Haemodynamic Parameters Obtained by PA Catheterisation
Figure 1: Changes in Haemodynamic Parameters Obtained by PA Catheterisation
Patient Characteristics
Patient Characteristics
Risk Factors for Aortic Dissection
Risk Factors for Aortic Dissection
Figure 5 Multibiomarker Panel for Identifying the Predominant Heart Failure Phenotype
Figure 5: Multibiomarker Panel for Identifying the Predominant Heart Failure Phenotype
Figure 4 Biomarkers for Improving Recognition and Management of High risk Patients
Figure 4: Biomarkers for Improving Recognition and Management of High-risk Patients
Figure 3 Interpreting Haemoconcentration and Haemodilution During Decongestion
Figure 3: Interpreting Haemoconcentration and Haemodilution During Decongestion